COMBINATION OF NICOTINAMIDE MONONUCLEOTIDE DERIVATIVES AND HISTAMINE H2 RECEPTOR ANTAGONISTS FOR VIRAL INFECTIONS
申请人:NUVAMID SA
公开号:US20210353656A1
公开(公告)日:2021-11-18
The present disclosure relates to combinations of histamine H2 receptor antagonist and Nicotinamide mononucleotide derivatives of formula (I)
or a compound of formula (Ia)
for use in the treatment and/or prevention of viral infections, such as respiratory infections, preferably coronavirus infections. The present disclosure further relates to pharmaceutical compositions comprising compounds of formula (I) for use in the treatment and/or prevention of viral infections.